Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Strides Receives USFDA Approval for Butalbital, Acetaminophen, and Caffeine Tablets
Details : Strides Pharma has received approval for Butalbital, Acetaminophen, and Caffeine Tablets USP, 50 mg/325 mg/40 mg from the U.S Food & Drug Administration. The product is indicated for the relief of the symptom complex of tension (or muscle contraction) he...
Product Name : Fioricet-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 22, 2020
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : USFDA approved generic version of Butalbital, Acetaminophen, Caffeine with Codeine Phosphate Capsules which is indicated for the relief of the symptom complex of tension headache (migraine).
Product Name : Fioricet-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 07, 2020
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Limited Announces Approval of Butalbital, Acetaminophen and Caffeine
Details : USFDA approved generic version of Butalbital, Acetaminophen, Caffeine Capsules which is indicated for the relief of the symptom complex of tension headache (migraine).
Product Name : Butalbital-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 04, 2020
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Senores Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of reference listed drug Butalbital, Acetaminophen, and Caffeine capsules of Mayne Pharma, indicated for relief of symptom complex of tension (or muscle con...
Product Name : Butalbital-Generic
Product Type : Controlled Substance
Upfront Cash : Inapplicable
March 17, 2022
Lead Product(s) : Butalbital,Paracetamol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Senores Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable